These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 14659814)

  • 41. Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS).
    Jensen LO; Vikman S; Antonsen L; Kosonen P; Niemelä M; Christiansen EH; Kervinen K; Erglis A; Harnek J; Kumsars I; Thuesen L; Niemelä K
    Cardiovasc Revasc Med; 2017 Dec; 18(8):577-582. PubMed ID: 29066343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
    Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
    Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial.
    Burzotta F; Brancati MF; Trani C; Pirozzolo G; De Maria G; Leone AM; Niccoli G; Porto I; Prati F; Crea F
    Heart Vessels; 2016 May; 31(5):677-86. PubMed ID: 25863804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intramural coronary delivery of advanced antisense oligonucleotides reduces neointimal formation in the porcine stent restenosis model.
    Kipshidze NN; Kim HS; Iversen P; Yazdi HA; Bhargava B; New G; Mehran R; Tio F; Haudenschild C; Dangas G; Stone GW; Iyer S; Roubin GS; Leon MB; Moses JW
    J Am Coll Cardiol; 2002 May; 39(10):1686-91. PubMed ID: 12020498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of postintervention and nine-month luminal enlargement after treatment of drug-eluting in-stent restenosis with a drug-eluting balloon.
    Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y
    Am J Cardiol; 2014 May; 113(9):1468-73. PubMed ID: 24607028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathophysiology of coronary artery restenosis.
    Schwartz RS; Henry TD
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S4-9. PubMed ID: 12478229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the pig coronary artery injury model: comparison of plain old balloon angioplasty and stent implantation].
    Shimizu N; Suzuki H; Wakabayashi K; Iso Y; Shibata M; Yorozuya M; Katagiri T; Takeyama Y
    J Cardiol; 2004 Mar; 43(3):131-9. PubMed ID: 15067801
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restenosis is not associated with stent length in a pig model of coronary stent implantation.
    Koutouzis M; Papalois A; Kyrzopoulos S; Dafnomili P; Kyriakides ZS
    Cardiol J; 2008; 15(5):458-62. PubMed ID: 18810722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
    Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Neointimal hyperplasia by luminal cell recruitment and not be transmural migration. The role of Bcl-2 and HSP47 after balloon angioplasty].
    Jabs A; Krämer S; Skowasch D; Welsch U; Kuhn A; Kandolf R; Lüderitz B; Bauriedel G
    Z Kardiol; 2002 Aug; 91(8):626-36. PubMed ID: 12426826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
    Alfonso F; Pérez-Vizcayno MJ; Cárdenas A; García Del Blanco B; Seidelberger B; Iñiguez A; Gómez-Recio M; Masotti M; Velázquez MT; Sanchís J; García-Touchard A; Zueco J; Bethencourt A; Melgares R; Cequier A; Dominguez A; Mainar V; López-Mínguez JR; Moreu J; Martí V; Moreno R; Jiménez-Quevedo P; Gonzalo N; Fernández C; Macaya C;
    J Am Coll Cardiol; 2014 Apr; 63(14):1378-86. PubMed ID: 24412457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
    Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
    Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment.
    Chung IM; Gold HK; Schwartz SM; Ikari Y; Reidy MA; Wight TN
    J Am Coll Cardiol; 2002 Dec; 40(12):2072-81. PubMed ID: 12505216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors for functionally significant in-stent restenosis: an integrated analysis using coronary angiography, IVUS, and myocardial perfusion imaging.
    Kang SJ; Cho YR; Park GM; Ahn JM; Han SB; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Lee CW; Park SW; Mintz GS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1183-90. PubMed ID: 24229771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sustained attenuation of neointimal coverage over the stent following brachytherapy for in-stent restenosis: angioscopic findings.
    Awata M; Kotani J; Nanto S; Uematsu M; Morozumi T; Hori M; Nagata S
    Circ J; 2006 Jul; 70(7):846-50. PubMed ID: 16799236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.
    Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ;
    Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An intravascular ultrasound analysis of the mechanisms of restenosis comparing drug-eluting stents with brachytherapy.
    Kim SW; Mintz GS; Escolar E; Ohlmann P; Pregowski J; Tyczynski P; Hassani SE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R; Weissman NJ
    Am J Cardiol; 2006 May; 97(9):1292-8. PubMed ID: 16635598
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
    [No Abstract]   [Full Text] [Related]  

  • 59. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses.
    Komatsu R; Ueda M; Naruko T; Kojima A; Becker AE
    Circulation; 1998 Jul; 98(3):224-33. PubMed ID: 9697822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation.
    Radke PW; Figulla HR; Drexler H; Klues HG; Mügge A; Silber S; Daniel W; Schmeisser A; Reifart N; Motz W; Büttner HJ; Fischer D; Ortlepp JR; Schaefers K; Hoffmann R; Hanrath P;
    Am Heart J; 2006 Oct; 152(4):761.e1-6. PubMed ID: 16996855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.